Zelira Therapeutics Ltd has released a press release.
March 2018 Quarterly Report
Filed with ASX ·
6ix hasn’t read this filing yet.
Zelira Therapeutics Ltd. on 6ix
Story so far
Earlier from Zelira Therapeutics
- Insomnia Clinical Trial Update-Patient Recruitment Completed
- Expansion of Pancreatic Cancer Research Programme
- Appendix 4D & FY18 Interim Financial Report
- Zelda joins with US Childrens Hospital for autism study
- Australian Regulators Approve Zelda Insomnia Clinical Trial
Later from Zelira Therapeutics
- Appointment of Managing Director
- Commencement of New Managing Director
- June 2018 Quarterly Report
- Zelda Forms New Partnership to Access German Market
- First Patient Dosed in Zelda Insomnia Trial
Follow Zelira Therapeutics into a list and get an email when it puts out news.
Follow Zelira Therapeutics